Advanced search
Publication Cover
Future Oncology Volume 8, 2012 - Issue 12
Submit an article Journal homepage
214
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Cancer and Heterogeneity of Obesity: A Potential Contribution of Brown Fat

Lev M BersteinLaboratory of Oncoendocrinology, N.N. Petrov Research Institute of Oncology, St. Petersburg197758, Russia. [email protected]View further author information
Pages 1537-1548 | Published online: 12 Dec 2012

References

  • Hill JO . Understanding and addressing the epidemic of obesity: an energy balance perspective.Endocr. Rev.27, 750–761 (2006).
  • Mitchell NS , CatenacciVA, WyattHR, HillJO. Obesity: overview of an epidemic.Psychiatr. Clin. North Am.34, 717–732 (2011).
  • Kurpad AV , VaradharajanKS, AeberliI. The thin–fat phenotype and global metabolic disease risk.Curr. Opin. Clin. Nutr. Metab. Care14, 542–547 (2011).
  • Berstein LM . Cancer of hormone-dependent tissues in the frame of main non-communicable diseases. Aesculap, St. Peterburg, Russia. 180 (2009).
  • Kaidar-Person O , Bar-SelaG, PersonB. The two major epidemics of the twenty-first century: obesity and cancer.Obes. Surg.21, 1792–1797 (2011).
  • Berstein LM . Macrosomy, Obesity and Cancer. Nova Science Publishers, NY, USA, 199 (1997).
  • Calle EE , RodriguezC, Walker-ThurmondK, ThunMJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.N. Engl. J. Med.348, 1625–1638 (2003).
  • Calle EE , KaaksR. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.Nat. Rev. Cancer4, 579–591 (2004).
  • Renehan AG , TysonM, EggerMet al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569–578 (2008).
  • Renehan AG , SoerjomataramI, TysonMet al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int. J. Cancer 126, 692–702 (2010).
  • Chen J . Multiple signal pathways in obesity-associated cancer.Obes. Rev.12, 1063–1070 (2011).
  • Harvey AE , LashingerLM, HurstingSD. The growing challenge of obesity and cancer: an inflammatory issue.Ann. N.Y. Acad. Sci.1229, 45–52 (2011).
  • Crosbie EJ , RobertsC, QianWet al. Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur. J. Cancer 48, 853–864 (2012).
  • Karelis AD , St-PierreDH, ConusFet al. Metabolic and body composition factors in subgroups of obesity: what do we know? J. Clin. Endocrinol. Metab. 89, 2569–2575 (2004).
  • Bershtein LM , KovalenkoIG. ‘Metabolically healthy’ people with obesity and metabolic signs of obesity in normal weight people: what is behind of it? Probl. Endocrinol. (Mos.)3, 47–51 (2010).
  • Yang Y , DongJ, SunKet al. Obesity and incidence of lung cancer: a meta-analysis. Int. J. Cancer doi: 10.1002/ijc.27719 (2012) (Epub ahead of print).
  • Sturm R . Increases in morbid obesity in the USA: 2000–2005.Public Health121, 492–496 (2007).
  • Khandekar MJ , CohenP, SpiegelmanBM. Molecular mechanisms of cancer development in obesity.Nat. Rev. Cancer11, 886–895 (2011).
  • Liu LN , MiaskowskiC, WangJSet al. Accuracy of body mass index to determine obesity in women with breast cancer: an observational study of Taiwanese sample. Int. J. Nurs. Stud. 47, 994–1000 (2010).
  • Schiaffino S , ReggianiC. Fiber types in mammalian skeletal muscle.Physiol. Rev.91, 1447–1531 (2011).
  • Hittel DS , BerggrenJR, ShearerJet al. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58, 30–38 (2009).
  • Zhang C , McFarlaneC, LokireddySet al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55, 183–193 (2012).
  • Murphy KT , CheeA, GleesonBGet al. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R716–R726 (2011).
  • Prado CM , LieffersJR, McCargarLJet al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 9(7), 629–635 (2008).
  • Stults-Kolehmainen MA , StanforthPR, BartholomewJB. Fat in android, trunk, and peripheral regions varies by ethnicity and race in college aged women.Obesity (Silver Spring)20, 660–665 (2012).
  • Petrek JA , PetersM, CirrincioneCet al. Is body fat topography a risk factor for breast cancer? Ann. Intern. Med. 118, 356–362 (1993).
  • Pischon T , NöthlingsU, BoeingH. Obesity and cancer.Proc. Nutr. Soc.67, 128–145 (2008).
  • Kershaw EE , FlierJS. Adipose tissue as an endocrine organ.J. Clin. Endocrinol. Metab.89, 2548–2556 (2004).
  • Berstein LM . Hormones of adipose tissue (adipocytokines): ontogenetic and oncologic aspects.Adv. Gerontol.16, 51–64 (2005).
  • Blüher M . Adipose tissue dysfunction in obesity.Exp. Clin. Endocrinol. Diabetes117, 241–250 (2009).
  • Sung MK , YeonJY, ParkSYet al. Obesity-induced metabolic stresses in breast and colon cancer. Ann. N.Y. Acad. Sci. 1229, 61–68 (2011).
  • Dilman VM , BersteinLM, OstroumovaMNet al. Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology 39, 13–19 (1982).
  • von Gruenigen VE , CourneyaKS, GibbonsHEet al. Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. Gynecol. Oncol. 109, 19–26 (2008).
  • Tokunaga M , HikiN, FukunagaTet al. Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br. J. Surg. 96, 496–500 (2009).
  • Guiu B , PetitJM, BonnetainFet al. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 59, 341–347 (2010).
  • Gomez-Santos C , Hernandez-MoranteJJ, MargaretoJet al. Profile of adipose tissue gene expression in premenopausal and postmenopausal women: site-specific differences. Menopause 18, 675–684 (2011).
  • Kilpeläinen TO , ZillikensMC, StančákovaAet al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat. Genet. 43, 753–760 (2011).
  • Andrade FH , FigueiroaFC, BersanoPRet al. Malignant mammary tumor in female dogs: environmental contaminants. Diagn. Pathol. 5, 45–47 (2010).
  • Berstein LM , KovalevskijAY, PoroshinaTEet?al. Signs of proinflammatory genotoxic switch (adipogenotoxicosis) in mammary fat of breast cancer patients: role of menopausal status, estrogens and hyperglycemia. Int. J. Cancer 121, 514–519 (2007).
  • Bershtein LM , Kovalevskiĭ AIu PoroshinaTEet al. Progenotoxic shift in mammary adipose tissue (adipogenotoxicosis): association with clinical and biological characteristics of breast cancer. Vopr. Onkol. 54, 294–302 (2008).
  • Iyengar P , EspinaV, WilliamsTWet al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J. Clin. Invest. 115, 1163–1176 (2005).
  • Carter JC , ChurchFC. Mature breast adipocytes promote breast cancer cell motility.Exp. Mol. Pathol.92(3), 312–317 (2012).
  • D’Esposito V , PassarettiF, HammarstedtAet al. Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia 55(10), 2811–22 (2012).
  • Sims EA . Are there persons who are obese, but metabolically healthy?Metabolism50, 1499–1504 (2001).
  • Calori G , LattuadaG, PiemontiLet al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34, 210–215 (2011).
  • Noppa H , BengtssonC, IsakssonB, SmithU. Adipose tissue cellularity in adulthood and its relation to childhood obesity.Int. J. Obes.4, 253–263 (1980).
  • Arner E , WestermarkPO, SpaldingKLet al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 59, 105–109 (2010).
  • Park KW , HalperinDS, TontonozP. Before they were fat: adipocyte progenitors.Cell Metab.8, 454–457 (2008).
  • Ahfeldt T , SchinzelRT, LeeYKet al. Programming human pluripotent stem cells into white and brown adipocytes. Nat. Cell Biol. 14, 209–219 (2012).
  • Zhang Y , BellowsCF, KoloninMG. Adipose tissue-derived progenitor cells and cancer.World J. Stem Cells2, 103–113 (2010).
  • Bellows CF , ZhangY, ChenJet al. Circulation of progenitor cells in obese and lean colorectal cancer patients. Cancer Epidemiol. Biomarkers Prev. 20, 2461–2468 (2011).
  • Medici D , KalluriR. Endothelial–mesenchymal transition and its contribution to the emergence of stem cell phenotype.Semin. Cancer. Biol.22(5–6), 379–384. (2012).
  • Seale P , BjorkB, YangWet al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961–967 (2008).
  • Ricquier D . Biology of brown adipose tissue: view from the chair.Int. J. Obes. (Lond.) (Suppl. 1), S3–S6 (2010).
  • Richard D , PicardF. Brown fat biology and thermogenesis.Front. Biosci.16, 1233–1260 (2011).
  • Frontini A , CintiS. Distribution and development of brown adipocytes in the murine and human adipose organ.Cell Metab.11, 253–256 (2010).
  • Chen YI , CypessAM, SassCAet al. Anatomical and functional assessment of brown adipose tissue by magnetic resonance imaging. Obesity (Silver Spring) 20(7), 1519–1526 (2012).
  • Cypess AM , LehmanS, WilliamsGet al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509–1517 (2009).
  • Ouellet V , Routhier-LabadieA, BellemareWet al. Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J. Clin. Endocrinol. Metab. 96, 192–199 (2011).
  • Townsend KL , TsengYH. Brown adipose tissue. Recent insights into development, metabolic function and therapeutic potential.Adipocyte1, 13–24 (2012).
  • Cinti S . Between brown and white: novel aspects of adipocyte differentiation.Ann. Med.43, 104–115 (2011).
  • Wang F , LiuH, BlantonWPet al. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem. J. 425, 71–83 (2009).
  • Waldén TB , HansenIR, TimmonsJAet al. Recruited vs. nonrecruited molecular signatures of brown, ‘brite,’ and white adipose tissues. Am. J. Physiol. Endocrinol. Metab. 302(1), E19–E31 (2012).
  • Wu J , BoströmP, SparksLMet al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150(2), 366–76 (2012).
  • Fisher FM , KleinerS, DourisNet al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26, 271–281 (2012).
  • Ohno H , ShinodaK, SpiegelmanBMet al. PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab. 5, 395–404 (2012).
  • Vitali A , MuranoI, ZingarettiMCet al. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J. Lipid Res. 53, 619–629 (2012).
  • Vegiopoulos A , Müller-DeckerK, StrzodaDet al. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 328, 1158–1161 (2010).
  • Fliers E , BoelenA. Type 2 deiodinase and brown fat: the heat is on – or off.Endocrinology151, 4087–4089 (2010).
  • Cypess AM , KahnCR. Brown fat as a therapy for obesity and diabetes.Curr. Opin. Endocrinol. Diabetes Obes.17, 143–149 (2010).
  • Whittle AJ , LópezM, Vidal-PuigA. Using brown adipose tissue to treat obesity – the central issue.Trends Mol. Med.17, 405–411 (2011).
  • Furlong MA , Fanburg-SmithJC, MiettinenM. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases.Am. J. Surg. Pathol.25(6), 809–814 (2001).
  • Nord KH , MagnussonL, IsakssonMet al. Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma. Proc. Natl Acad. Sci. USA 107(49), 21122–21127 (2010).
  • Russell AP , CrisanM, LégerBet al. Brown adipocyte progenitor population is modified in obese and diabetic skeletal muscle. Int. J. Obes. (Lond.) 36, 155–158 (2012).
  • Nitzki F , ZibatA, FrommholdAet al. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice. Oncogene 30(43), 4428–4436 (2011).
  • Lee P , ZhaoJT, SwarbrickMMet al. High prevalence of brown adipose tissue in adult humans. J. Clin. Endocrinol. Metab. 96, 2450–2455 (2011).
  • Huang YC , ChenTB, HsuCCet al. The relationship between brown adipose tissue activity and neoplastic status: an (18)F-FDG PET/CT study in the tropics. Lipids Health Dis. 10, 238–243 (2011).
  • Aukema TS , VogelWV, HoefnagelCA, Valdés OlmosRA. Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy.J. Nucl. Med. Technol.38, 24–27 (2010).
  • Rousseau C , BourboulouxE, CampionLet al. Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT scans. Eur. J. Nucl. Med. Mol. Imaging 33, 785–791 (2006).
  • Ortega-Molina A , EfeyanA, Lopez-GuadamillasEet al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab. 15, 382–394 (2012).
  • Jones LP , BueltoD, TagoE, Owusu-BoalteyKE. Abnomal mammary adipose tissue environment of Brca1 mutant mice show a persistent deposition of highly vascularized multilocular adipocytes.J. Cancer Sci. Ther.S2, 1–6 (2011).
  • Shakya R , SzabolcsM, McCarthyEet al. The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc. Natl Acad. Sci. USA 105(19), 7040–7045 (2008).
  • de Moura MB , dos SantosLS, Van HoutenB. Mitochondrial dysfunction in neurodegenerative diseases and cancer.Environ. Mol. Mutagen.51, 391–405 (2010).
  • Paz-Filho G , LimEL, WongML, LicinioJ. Associations between adipokines and obesity-related cancer.Front. Biosci.16, 1634–1650 (2011).
  • Santen R , CavalieriE, RoganEet al. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann. N.Y. Acad. Sci. 1155, 132–140 (2009).
  • Berstein LM . Role of endocrine–genotoxic switchings in cancer and other human diseases: basic triad.Adv. Exp. Med. Biol.630, 35–51 (2008).
  • Bansal N , YendluriV, WenhamRM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies.Cancer Control16, 8–13 (2009).
  • Kunkel SD , ElmoreCJ, BongersKSet al. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One 7(6), e39332 (2012).
  • Wu B , WangX, ChiZFet al. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway. Arch. Pharm. Res. 35(3), 543–548 (2012).
  • Foulkes WD . Clinically relevant biology of hereditary breast cancer.Semin. Oncol.34(5), 379–383 (2007).
  • Rosen EM , FanS, IsaacsC. BRCA1 in hormonal carcinogenesis: basic and clinical research.Endocr. Relat. Cancer12, 533–548 (2005).
  • Berstein LM . Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis.Future Oncol.4, 23–39 (2008).
  • Dellas A , JundtG, SartoriusGet al. Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas. Clin. Cancer Res. 15(7), 2456–2462 (2009).
  • M⊘ller P , MaehleL, Vab⊘Aet al. Age-specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway. Clin Genet. doi: 10.1111/j.1399-0004.2012.01855.x (2012) (Epub ahead of print).
  • Cannon B , NedergaardJ. Cell biology: neither brown nor white.Nature488, 286–287 (2012).
  • Hamer M , StamatakisE. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality.J. Clin. Endocrinol. Metab.97, 2482–2488 (2012).
  • Ortega FB , LeeDC, KatzmarzykPTet al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur. Heart J. doi: 10.1093/eurheartj/ehs174 (2012) (Epub ahead of print).
  • Bokhman JV . Two pathogenetic types of endometrial carcinoma.Gynecol. Oncol.15, 10–17 (1983).
  • Scata KA , El-DeiryWS. p53, BRCA1 and breast cancer chemoresistance.Adv. Exp. Med. Biol.608, 70–86 (2007).
  • Brunet J , Vazquez-MartinA, ColomerRet al. BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer. Mol. Carcinog. 47, 157–163 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.